基于CRISPR/Cas的ex vivo基因疗法和溶酶体储存障碍:超越Cas9的视角
Andrés Felipe Leal1,2,3, Luis Eduardo Prieto2, Harry Pachajoa1,2,4
1Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras, Universidad Icesi, Cali 760031, Colombia.
Cells
|August 13, 2025
概括
使用CRISPR/Cas系统的基因疗法为溶酶体储存障碍 (LSD) 提供了新的治疗方法. 先进的CRISPR策略和ex vivo基因编辑显示出纠正LSDs遗传缺陷的希望.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 溶酶体储存障碍 (LSD) 是由酶缺乏引起的遗传代谢疾病.
- lysosomes 中基质的积累导致细胞功能障碍和疾病病理.
- 基因疗法,特别是CRISPR/Cas系统,正在成为LSD的潜在治疗方法.
研究的目的:
- 审查CRISPR/Cas技术用于治疗LSDs的分子机制.
- 讨论CRISPR/Cas系统在LSDs的ex vivo基因治疗策略中的应用.
- 探索基于CRISPR的新方法,超越经典的CRISPR/Cas9系统,用于LSD治疗.
主要方法:
- 审查CRISPR/Cas系统,包括CRISPR/Cas9,基础编辑,主要编辑和HITI.
- 对LSDs的ex vivo基因编辑方法的分析,特别是那些影响中枢神经系统的基因编辑方法.
- 直接给药与ex vivo基因治疗策略的讨论.
主要成果:
- 克里斯普尔/卡斯系统使得精确的基因组编辑能够进行有针对性的基因修改.
- 克里斯普尔/Cas9已被用于LSD疾病建模和基因纠正通过同源重组.
- 新的CRISPR策略和ex vivo方法为LSDs提供了创新的治疗途径.
结论:
- 克里斯普尔/卡斯技术,包括先进的变体和活体应用,具有治疗溶酶体储存障碍的巨大潜力.
- 活体基因编辑策略对于影响中枢神经系统的LSD特别重要.
- 对基于CRISPR的新方法的持续研究有望推进LSD疗法.
相关概念视频
01:59CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
01:28CRISPR/Cas9 Genome Editing
220
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
220
02:53CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K
00:49What is Genetic Engineering?
75.5K
Overview
75.5K
00:59Gene Therapy
25.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.9K
02:31Homologous Recombination
52.0K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
52.0K